Professor Angela Wallace was appointed as the Board’s Nurse Director in April 2022.
Angela joined the Board from NHS Forth Valley where she had been Board Nurse Director since 2004. In addition, following her appointment by Scottish Government in February 2020 to the post of Interim Director for Infection Prevention and Control with NHSGGC, Angela has also provided leadership, guidance and assurance to our Board on the management and prevention of infection within our services.
She brings a wealth of experience leading nursing, midwifery and allied health professions.
Professor Angela Wallace’s achievements include the delivery of a comprehensive Quality and Safety strategy and the development of the country’s first nursing and midwifery care assurance system to drive performance improvement in nursing care.
David Gould is appointed a non-executive member from 1st February 2022 and subsequently appointed Vice Chair of the Board from 1st January 2025.
David Gould, a graduate of University of Strathclyde Business School, qualified as a Member of the Institute of Chartered Accountants of Scotland in 1997, having trained with Price Waterhouse.
He has devoted his career to working in the public sector. David has occupied Finance roles within Scottish Enterprise and NHS 24 during its key start-up and roll-out phase, before being appointed Head of Corporate Services for Glasgow City Marketing Bureau; responsible for the successful delivery of corporate governance, HR, IT, Legal and Risk Management.
David has held Non-Executive positions within Registers of Scotland and Forestry Commission Scotland during periods of significant organisational challenge and change, and is currently a Non-Executive Director for GoFar Enterprises, a specialist media publisher and the Chairman of an after school care provider.
He is committed to helping to contribute to the people of Glasgow receiving the highest possible level of health and social care though optimising the use of available resources, skills and knowledge.
Outside of work, he is an award-winning sports journalist and photographer.
Emilia became a member of the NHS Board in February 2022.
Emilia qualified in Medicine in 1991 and after gaining the Royal College of Physician exams, she joined the West of Scotland training scheme for Public Health Medicine. During this time, she gained a Master in Public Health (Glasgow University 2000) and became Member of the Faculty of Public Health (2004). In 2006 she was elected Fellow of the Faculty of Public Health and served two terms as Convenor of the Faculty of Public Health in Scotland.
Emilia joined NHS Greater Glasgow in 2006 as a Consultant in Public Health Medicine and was appointed lead clinician for screening programmes; head of Health Services Section; Deputy Director of Public Health; and during 2015 and 2016 and again in 2022 Interim Director of Public Health. Emilia was appointed Director of Public Health in August 2023.
Emilia led the implementation and ongoing delivery of new national screening programmes like abdominal aortic aneurysm; and bowel screening; was a strong advocate for healthy public health policy like the introduction of a minimum price per unit of alcohol sold; sugar tax; and effective drug addiction interventions. She remains passionate about effective health preventative interventions including those addressing the fundamental causes of ill health like poverty and inequity.
Ann Cameron-Burns is appointed as a non-executive member from 1st January 2022 until 31st December 2025.
Ann joined the NHS Argyll and Clyde Health Board over 20 years ago as a Health Promotion Officer. She has been an active trade unionist for over 40 years, becoming a member of UNISON in 1993.
Ann’s main focus is on equalities, specifically representing the LGBT+ community.
Elected by her joint trade union colleagues, Ann took up the post of Employee Director for NHS Greater Glasgow and Clyde on 1st January 2022.
Michelle Wailes is a Fellow of the Institute of Chartered Accountants in England and Wales, with over 18 years’ experience in the professional and financial services industries and the public sector.
She started her career with PricewaterhouseCoopers, working in the Government and Public Sector team. During this time she was engaged on the delivery of statutory audit services, internal audit services and specialist advisory projects across a wide range of Public Sector Bodies in Scotland and the South East of England.
She then spent 10 years working at the Clydesdale and Yorkshire Bank Group where she gained extensive experience in internal audit, risk and corporate governance.
Michelle Wailes is currently a Board Member and Chair of the Audit and Risk Committee at Scottish Canals, and a member of the Police Investigations and Review Commissioner Audit and Accountability Committee.
Other information
Expenses claims
No expense claims have been declared.
Hospitality
No hospitality declared
Register of interest
Board Member, Scottish Canals
Board Member and Chair of the Audit and Risk Committee, SQA
Member of the Audit and Accountability Committee, Police Investigations and Review Commissioner
Charles Vincent is appointed as a non-executive member from 1st February 2020 until 31st May 2025.
Charles is a highly experienced corporate board member, working in highly regulated industries and their accompanying governance.
He has also been a Children’s Hearing Scotland panel member for a number of years making complex decisions about the futures of vulnerable children in partnership with the various agencies involved in their lives.
He brings to the board his vast experience of developing high performance cultures that are able to continuously improve through supportive self-analysis. This includes managing the complex disagreements that inevitably occur when there are conflicting priorities within an organisation.
Charles Vincent has lived his whole life in Glasgow and is committed to ensuring that its residents get the very best healthcare possible.
Dr Lesley Rousselet is appointed as a non-executive board member from 1st July 2021 until 30th June 2023.
Lesley works as a community based, independent prescribing optometrist, having qualified in Optometry from Aston University in 1996, with a PhD in Vision Sciences in 2013.
Within NHSGGC, she currently holds the position of Chair of the Area Clinical Forum.
Dr Lesley Rousselet is joint Programme Director for Optometry in NHS Education for Scotland, and is driven by a passion for accessible and excellent patient care.
Other information
Expenses claims
No expense claims have been declared.
Hospitality
No hospitality declared
Register of interest
Programme Director Optometry, NHS Education for Scotland
Ketki Miles is appointed as a non-executive board member from 1st June 2020 until 31st May 2024.
Ketki has 32 years’ experience working for a global financial services organisation.
She has worked in a wide range of senior leadership roles in the UK, Europe, Asia and the US, with experience in working with diverse and dispersed teams.
Ketki brings strengths in operational leadership, strategy, and change management.
She holds a Bachelor of Arts in Computer Science.
Ketki Miles has an appreciation of the challenges the NHS faces nationally and in Greater Glasgow and Clyde and is looking forward to making a contribution.
Professor Iain McInnes is appointed as a non-executive board member from 1st April 2021 until 31st March 2025.
Iain is Vice Principal and Head of the College of Medical, Veterinary and Life Sciences, Muirhead Chair of Medicine and Versus Arthritis Professor of Rheumatology at the University of Glasgow, Glasgow, United Kingdom. He is also Director of the Versus Arthritis Centre of Excellence for Inflammatory Arthritis, led from Glasgow and including Universities of Oxford, Newcastle, and Birmingham.
He is immediate past chairman of the FOREUM (Foundation for European Rheumatology Research) Scientific Committee, leads the European Roadmap programme that is defining the research agenda for European rheumatology for the next decade, and is currently President of EULAR (European Alliance of Associations for Rheumatology), the leading trans-national society for rheumatology across Europe. Under these auspices, he is creating the first pan-European Rheumatology Research Centre, launching in 2021.
Over two decades, he has led numerous clinical trials and pathogenesis investigation programmes in inflammatory arthritis at an international level. His work is focused on understanding the pathogenesis of immune mediated inflammatory diseases and encompasses basic discovery immunology through phase 1 and proof of concept experimental medicine clinical trials to leadership of pivotal phase 3 trials in immune biology. His original discovery work has led to the therapeutic targeting of several inflammatory cytokines. More recently, he has focused on the biology of myeloid cells in the pathogenesis of a number of immune diseases. He has published >400 peer-reviewed original and review articles with an h-index >100.
Professor Iain McInnes is a Fellow of the Royal Society of Edinburgh and the Academy of Medical Sciences. He is the recipient of several prestigious prizes in recognition of his work, including the Sir James Black Medal of the Royal Society of Edinburgh in 2017, the Heberden Medal of the British Society for Rheumatology in 2018, and the Carol-Nachman Prize for Rheumatology, Germany (the highest international award in rheumatology) in 2019. He was awarded a CBE for services to medicine by Her Majesty the Queen in 2019.
